Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 2020 Aug 24;86(9):1894. doi: 10.1111/bcp.14497

Correction

PMCID: PMC7444759  PMID: 33464570

In column 2 of page 635, the reference Weatherburn et al (2019) 1 is to be inserted at the end of the sentence “The Achilles heel of regulatory pharmacovigilance remains the ability to change behaviour. Examples of effective action are included in the paper by Weatherburn et al.”

REFERENCES

  • 1. Weatherburn CJ, Guthrie B, Dreischulte T, Morales DR. Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: systematic review, time series analysis and meta‐analysis. Br J Clin Pharmacol. 2020;86(4):698‐710. 10.1111/bcp.14104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Arlett P. Measuring the impact of risk communications: robust analytical approaches are key. Br J Clin Pharmacol. 2020;86(4):635‐636. 10.1111/bcp.14222 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES